Liva is delighted to be provisionally selected as one of the leading digital therapeutics platforms to offer hybrid weight-loss programmes in partnership with the National Health Service (NHS).

The National Institute for Health and Care Excellence (NICE) has published new draft guidance that will allow NHS patients to be referred to digital weight management services and prescribed weight-loss medication. Liva is one of four digital therapeutics platforms that have been recommended to support patients throughout their treatment. NICE relied heavily on Liva’s extensive clinical evidence in drawing up the draft guidance for these new measures to tackle the obesity crisis.

Liva has a range of clinical studies showcasing remarkable results. Patients in one study lost 4.5kg in six months supported by Liva’s lifestyle change coaching platform. In contrast, those using conventional methods reported weight loss of only 1.5kg. Liva’s hybrid approach combines digital engagement with one to one clinical coaching and can be delivered at scale.

These programmes, endorsed by the National Institute for Health and Care Excellence (NICE), leverage the potential of these digital platforms. Accessible through apps and computers, they enable healthcare specialists to provide comprehensive care and support online. This innovative approach addresses the challenges posed by the limitations of traditional face-to-face services which are overburdened with long waiting lists to access services.

A consultation on the recommendations is taking place and NICE expects to publish final guidance on Thursday, 28 September 2023.

About Liva Healthcare

Liva is a leading digital therapeutics company that advances digital-first delivery of behaviour change programmes to improve health outcomes globally, at scale. Our team of dedicated healthcare professionals create personalised change programmes to support people in their journey to prevent, manage and treat obesity, type-2 diabetes and prediabetes and other cardiometabolic conditions.

The safety and efficacy of our digital therapeutic programmes are well-supported by extensive evidence from randomised controlled trials (RCTs) and other real-world evidence studies. Liva’s innovative digital-first coaching platform integrates seamlessly into healthcare systems offering personalised clinical support to more than 45,000 people.

Founded in Denmark, we have expanded our reach across multiple geographies, marking our presence as a global force for advancing better health outcomes. Our collaborations with healthcare systems, including the NHS, as well as partnerships with some of the world’s largest life science companies and health insurers allow us to impact lives on a large scale.

Please visit www.livahealthcare.com and follow us on Linkedin on @LivaHealth.